Finally, we mutated in IL6‐AS1 for miR‐149‐5p and EBF1 individually and simultaneously to confirm the synergistic effect, which suggests that IL6‐AS1 may be a causative agent in the development of COPD. Here, EBF1 is linked to chronic obstructive pulmonary disease.